Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the
...Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration of funds duly paid pursuant to that certain Underwriting Agreement by
or on behalf of and between SOLUNA HOLDINGS, INC., a Nevada corporation (the "Company"), and Univest Securities, LLC, dated April [●], 2022 (the "Underwriting Agreement"), [●]
("Holder"), (the "Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning from [●],
2022 ...20222 (the "Commencement "Exercise Date"), and at or before 5:00 p.m., Eastern time, on [●], 2026 20273 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [●]1 shares (the "Shares") of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), ("Common Stock"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share share and the number of Shares shares of Common Stock to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price as set forth above or the adjusted exercise price, price as a result of the events set forth in Section 6 below, depending on the context. Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Genprex, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [ ] [DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [ ] [DATE THAT IS FIVE YEARS FROM THE CLOSING DATE OF THE OFFERING] (the "Expira
...tion Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [ ] shares (the "Warrant Shares") of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $ per Share; Warrant Share (125% of the price of the shares of common stock sold in the proposed initial public offering of Shares (the "Offering"); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Warrant Share and the number of Warrant Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean the date that the Company's Registration Statement on Form S-1 (File No. 333-219386) is declared effective under the Securities Act of 1933, as amended (the "Securities Act") by the U.S. Securities and Exchange Commission (the "Commission").
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [ ] ("Holder"), as registered owner of this
Common Stock Purchase
Warrant, Warrant (this "Purchase Warrant"), to
Tenon Medical, Summit Semiconductor, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [ ] [DATE THAT IS 180 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026...[●] [ ] shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[ ] per Share; Share [125% of the price of the shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. This Purchase Warrant is being issued pursuant to the certain Underwriting Agreement (the "Underwriting Agreement"), dated [ ], 2018, by and among the Company, the Holder and other underwriters named therein, providing for the public offering (the "Offering") of shares of common stock, par value $0.0001 per share, of the Company (the "Common Stock"). The term "Effective Date" shall mean the effective date of the Offering. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] EF Hutton, division of Benchmark Investments, LLC ("Holder"), as registered owner of this Purchase
Warrant, to Tenon Medical, Inc., Warrant Yoshiharu Global Co., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from March 8, 2023 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 September 8, 2027 (the "Expiration Date"), but
...not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [ ] shares of Class A common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $5.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean September 8, 2022, the date on which the Registration Statement on Form S-1 (File No. 333- 262330) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Equity Trust Company Custodian, FBO: Rawleigh Hazen Ralls IRA ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Edison Nation, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from the date hereof (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 December 31, 2020 (the "Expiration Date")
..., but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 125,000 shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] a fixed amount of $2.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., GREENVISION ACQUISITION CORP., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [ ], 2021 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 on the five year Anniversary of the Commencement Date (the "Expiration Date"), but not thereafter, t
...o subscribe for, purchase and receive, in whole or in part, up to [●] shares of Company Class A common stock of the Company, stock, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. Warrant, except as otherwise provided herein or with the Holder's consent. This Purchase Warrant is initially exercisable at $[●] $11.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. This Purchase Warrant is being issued in connection a Subscription Agreement entered into on [ ], 2021 (the "Subscription Agreement"), and any capitalized terms used but not otherwise defined herein shall have the meaning given to them in the Subscription Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [·] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Signal Genetics, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [·], 2016 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [·], 2020 (the "Expiration
Date"), Date," which date shall not be more than five years from the effective date... of the registration statement on form S-1 (Registration No. 333-201533) of the Company (the "Registration Statement")), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [·] shares of common stock of the Company, par value $0.00001 $0.01 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[·] per Share; Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Platinum Arc LLC ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Healthcare Triangle, Inc., a Delaware corporation (the "Company"), Holder is entitled,
at any time or from
time to time beginning [●], April 11, 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], October 12, 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, i
...n whole or in part, up to [●] 261,000 shares of common stock of the Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $4.40 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean October 12, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-259180) of the Company was declared effective by the Securities and Exchange Commission ("Registration Statement").
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Dawson James Securities, Inc. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Great Basin Scientific, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [ ] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and
until at or before 5:00 p.m., Eastern time,
[●], 2026 [ ] [DATE THA...T IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [ ] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[ ] per Share; Share [125% of the public price of the Company's common stock and Series A Warrant combination sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], the date on which the Registration Statement on Form S-1 (File No. 333-197954) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Joseph T. Rallo ("Holder"), as registered owner of this Purchase
Warrant, to Tenon Medical, Warrant of Stran & Company, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], from May 12, 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], November 12, 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purcha
...se and receive, in whole or in part, up to [●] 62,287 shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and Exchange Commission.
View More
